XFOR Return on Tangible Equity | X4 PHARMACEUTICALS, INC

X4 PHARMACEUTICALS, INC (XFOR) Return on Tangible Equity

2026-06-30: Return Tang Equity -72.11%.
2026-03-31: Return Tang Equity -70.21%.
2025-12-31: Return Tang Equity -49.60%.
2025-09-30: Return Tang Equity -273.03%.

Complete source-backed return tang equity history.

Available history: 2016-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-72.11%
2026-03-31	-70.21%
2025-12-31	-49.60%
2025-09-30	-273.03%
2025-06-30	443.28%
2025-03-31	-345.92%
2024-12-31	719.92%
2024-09-30	-52.24%
2024-06-30	26.42%
2024-03-31	790.15%
2023-12-31	-299.77%
2023-09-30	-221.21%
2023-06-30	-259.89%
2023-03-31	-279.45%
2022-12-31	-165.55%
2022-09-30	-213.43%
2022-06-30	-735.41%
2022-03-31	-284.23%
2021-12-31	-188.47%
2021-09-30	-184.96%
2021-06-30	-123.14%
2021-03-31	-89.37%
2020-12-31	-135.98%
2020-09-30	-87.17%
2020-06-30	-70.50%
2020-03-31	-57.89%
2019-12-31	-51.72%
2019-09-30	-102.41%
2019-06-30	-63.92%
2019-03-31	-1809.69%
2018-12-31	43.18%
2018-09-30	32.24%
2018-06-30	42.13%
2018-03-31	46.28%
2017-12-31	49.37%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-49.60%
2024-12-31	719.92%
2023-12-31	-299.77%
2022-12-31	-165.55%
2021-12-31	-188.47%
2020-12-31	-135.98%
2019-12-31	-51.72%
2018-12-31	43.18%
2017-12-31	49.37%
2016-12-31	99.67%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Inhibikase Therapeutics, Inc. (IKT)	United States	$0.296B	-4.44
SAB Biotherapeutics, Inc. (SABS)	United States	$0.306B	-25.49
Century Therapeutics, Inc. (IPSC)	United States	$0.306B	-4.02
Liminatus Pharma, Inc. (LIMN)	United States	$0.282B
FATE THERAPEUTICS INC (FATE)	United States	$0.280B	-2.51
Lexeo Therapeutics, Inc. (LXEO)	United States	$0.278B	-4.19
PALISADE BIO, INC. (PALI)	United States	$0.275B	-11.41
Invivyd, Inc. (IVVD)	United States	$0.270B	-2.42
SUTRO BIOPHARMA, INC. (STRO)	United States	$0.260B	-3.05
Ocugen, Inc. (OCGN)	United States	$0.343B	-6.34